Employees: 1,794
Size Sichuan Goldstone Asia Pharmaceutical (300434.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $639M, the 3097th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥10.80 on 18 Nov 2026.
Performance Over six months the shares fell 6.1%, against -25.0% for the median peer and -20.0% for the China market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue fell 1.3% over the last twelve months (peer median +5.2%); the operating margin is 17.9% (peer median 1.4%).
Valuation It trades at 3.6× enterprise value to sales against a peer median of 2.3× (6th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.1 points below its cost of capital (9.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.04B | CN¥1.03B | CN¥1.09B | CN¥1.20B | CN¥1.23B |
| Revenue growth | — | -6% | -9% | -3% | — |
| Gross profit | CN¥676M | CN¥540M | CN¥566M | CN¥683M | CN¥705M |
| EBITDA | n/a | CN¥242M | CN¥231M | CN¥341M | CN¥368M |
| Net income | CN¥176M | CN¥132M | CN¥91.8M | CN¥126M | CN¥219M |
| Free cash flow | CN¥162M | CN¥109M | CN¥87.0M | CN¥86.0M | CN¥271M |
| Capital expenditure | CN¥97.3M | CN¥99.6M | CN¥72.9M | CN¥66.1M | CN¥54.1M |
| Total debt | CN¥112M | CN¥125M | CN¥144M | CN¥175M | CN¥93.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300434.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -11.8% | -11.1% | 11th highest of 21 |
| 6-month return | -6.1% | -25.0% | 5th highest of 21 |
| Distance from 52-week high | -25.1% | -45.2% | 4th highest of 21 |
| Revenue growth (TTM) | -1.3% | +5.2% | 5th lowest of 21 |
| Operating margin | 17.9% | 1.4% | 2nd highest of 21 |
| EV / Sales | 3.6× | 2.3× | 6th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 9.2% | 5.8% | 5th most demanding of 11 |
| Growth delivered (Del g) | +6.2% | +4.3% | 5th highest of 11 |
| Hurdle (Req g minus delivered) | +3.0 pp | -0.0 pp | 4th most demanding of 11 |
| ROIC minus cost of capital | -0.1 pp | -6.4 pp | 8th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Sichuan Goldstone Asia Pharmaceutical 300434.SZ | China | $639M | -6% | -1% | 18% | 3.6× | 9.2% | +6.2% |
| Jiangsu Boiln Plastics 301003.SZ | China | $646M | -19% | +7% | 20% | 6.0× | 19.9% | +3.6% |
| Jinhua Chunguang Technology 603657.SS | China | $662M | +13% | +22% | -4% | 1.7× | n/a | n/a |
| Zhejiang Tiantie Science & Technology 300587.SZ | China | $665M | -46% | +24% | -4% | 3.2× | n/a | n/a |
| Daoming Optics & Chemical 002632.SZ | China | $676M | -33% | -10% | 12% | 3.0× | 5.8% | +3.3% |
| Jiangyin Huaxin Precision Technology 603370.SS | China | $584M | -52% | +11% | 7% | 2.3× | n/a | n/a |
| Fuling Technology 001356.SZ | China | $704M | -33% | +17% | 6% | 2.0× | n/a | n/a |
| Hubei Huaqiang High-Tech 688151.SS | China | $718M | -29% | +13% | -5% | 2.9× | 41.6% | -5.6% |
| Chongqing Sulian Plastic 301397.SZ | China | $552M | -40% | +3% | 2% | 2.4× | n/a | n/a |
| Shenzhen Absen Optoelectronic 300389.SZ | China | $543M | -26% | +13% | 8% | 0.8× | -2.6% | +20.4% |
| Changyuan Technology 600525.SS | China | $760M | -24% | +7% | -7% | 0.9× | -12.9% | +5.1% |
| RHI Magnesita India RHIM.NS | India | $763M | -10% | +4% | 8% | 1.8× | 25.2% | +24.1% |
| Shenzhen Jame Technology 300868.SZ | China | $764M | -56% | +8% | -7% | 7.0× | n/a | n/a |
| Unilumin 300232.SZ | China | $772M | -23% | +1% | 0% | 0.7× | 5.9% | +10.3% |
| Zhejiang Kaier New Materials 300234.SZ | China | $774M | +43% | -17% | -9% | 17.4× | n/a | n/a |
| Aishida 002403.SZ | China | $522M | -3% | +1% | -9% | 1.8× | 51.3% | -1.5% |
| Shenzhen Chuangyitong Technology 300991.SZ | China | $520M | -49% | -10% | -1% | 5.8× | n/a | n/a |
| Guangdong Xiongsu Technology 300599.SZ | China | $519M | -19% | -15% | -16% | 3.5× | n/a | n/a |
| Zhejiang Goldensea Hi-Tech 603311.SS | China | $791M | -3% | +3% | 7% | 5.6× | n/a | n/a |
| Blue Sail Medical 002382.SZ | China | $801M | -21% | +23% | 7% | 1.2× | -7.2% | -6.1% |
| Guangdong Sunwill Precising Plastic 002676.SZ | China | $504M | -30% | +1% | 4% | 1.6× | 5.6% | +10.9% |